United States: Federal Circuit Considers Offers For Sale Under AIA, Suggests That Congress Did Not Discard All Pre-AIA Prior Art Definitions

Helsinn Healthcare, SA v. Teva Pharmaceuticals USA, Inc., No. 2016-1284 (Fed. Cir. May 1, 2017)

The Leahy Smith America Invents Act ("AIA") amended the Patent Act's novelty provisions for all applications having an effective filing date on or after March 16, 2013. The U.S. Patent and Trademark Office has instructed examiners that under the revised statute, public uses and offers for sale are available as prior art only if they make an invention available to the public, and secret or confidential uses and offers for sale are not prior art events. See, e.g., MPEP § 2152.02. In a recent case, a panel of the U.S. Court of Appeals for the Federal Circuit considered the AIA's impact on offers for sale as prior art. In a narrow decision, the court concluded that under the AIA, a prior art offer for sale need not publicly disclose a claimed invention if the offer itself is public. Further, the court's analysis suggests that it is likely to disagree with the USPTO's interpretation of the AIA in other respects, and may continue to apply pre-AIA case law governing prior art.


The Helsinn case arose from a dispute under the Hatch-Waxman Act, 35 U.S.C. § 271(e)(2). Helsinn obtained four patents covering products used to reduce nausea and other side effects of chemotherapy in cancer patients. Three of the patents resulted from applications filed prior to March 16, 2013, and thus were governed by pre-AIA § 102. The fourth patent, U.S. Patent No. 8,598,219, issued from an application filed after March 16, 2013 and was governed by AIA § 102(a)(1). Teva filed an Abbreviated New Drug Application seeking market approval for a generic form of Helsinn's product, and Helsinn responded by filing an infringement action asserting all four patents against Teva.

In the litigation, Teva contended that the Helsinn patents were invalid because the claimed inventions were the subject of a commercial offer for sale more than one year before the patent application filing dates. The district court ruled in favor of Helsinn on two grounds. First, the district court held that the invention was not "ready for patenting" more than one year before the application filing date, because the U.S. Food and Drug Administration ("FDA") did not approve the product for sale. Second, as to the '219 patent, the district court held that the alleged offer for sale did not qualify as prior art under the AIA because the offer did not publicly disclose the invention. Teva appealed to the Federal Circuit.

Federal Circuit Decision

In a panel decision written by Circuit Judge Timothy Dyk, the Federal Circuit reversed the district court and ruled that the Helsinn patents were invalid.

The court ruled that the three pre-AIA patents were invalid due to a statutory bar, pre-AIA 35 U.S.C. § 102(b). An on-sale bar requires (a) a commercial offer to sell the invention, and (b) that the invention is "ready for patenting," both more than one year before the application filing date. See Pfaff v. Wells Electronics, Inc., 525 U.S. 55 (1998). Helsinn and a supplier had entered into a supply agreement for products covered by the patent claims, and the agreement was publicly disclosed as part of an SEC filing (although some technical details were redacted). The appeals court ruled that the supply agreement contained all the material terms for an enforceable agreement and thus was a prior art offer for sale, even though any actual sale of products was contingent on FDA approval.

Federal Circuit Addresses AIA Prior Art

The most significant discussion in the court's decision concerns the AIA's effect on the on sale bar defense. AIA 35 U.S.C. § 102(a)(1) states that:

A person shall be entitled to a patent unless—

(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention;

The district court held, consistent with the USPTO's interpretation of the AIA, that a reference is prior art under the AIA only if it is "available to the public." Thus, it ruled, confidential offers for sale cannot attain the status of prior art. In a narrow decision, confronting only the effect of the AIA on offers for sale as prior art, the Federal Circuit rejected that interpretation.

First, the Federal Circuit noted that for many years courts have considered public uses and offers for sale to be prior art even if they did not come to the attention of the public. In a famous case, for example, a new design for a corset worn under a dress was a public use, even though the invention was not visible when used. Egbert v. Lippman, 104 U.S. 333 (1881). The court traced the principle that a commercial use by an inventor is a prior art reference, even if it does not result in the disclosure of the invention to the public, back to Pennock v. Dialogue, 27 U.S. (2 Pet.) 1 (1829).

Second, the Federal Circuit was not persuaded by the legislative history of the AIA, including floor statements by legislators during debate, that Congress intended to abrogate the pre-AIA case law defining prior art. Some floor statements expressed an intent to eliminate private public uses as prior art, and even named Egbert and similar cases. The court noted, however, that none of the statements expressly called for overruling pre-AIA cases involving confidential offers for sale. Moreover, the court did not view the legislative history as strong enough to create the general requirement that prior art references must disclose the claimed invention to the public, since, "[r]equiring such disclosure as a condition of the on-sale bar would work a foundational change in the theory of the statutory on-sale bar." Slip op. at 22. It stated:

[O]ur prior cases have applied the on-sale bar even when there is no delivery, when delivery is set after the critical date, or, even when, upon delivery, members of the public could not ascertain the claimed invention. There is no indication in the floor statements that these [Congress] members intended to overrule these cases. . . . If Congress intended to work such a sweeping change to our on-sale bar jurisprudence and wished to repeal . . . [these prior] cases legislatively, it would do so by clear language.

Slip op. at 26 (citation omitted). Thus, although the AIA unambiguously changed some requirements for prior art status, such as eliminating the pre-AIA requirement that public uses and offers for sale occur in the United States, the Act did not clearly withdraw prior art status from secret offers for sale.

Deciding the case narrowly, the Federal Circuit ruled that the Helsinn supply agreement was a prior art offer for sale because the agreement itself was available to the public, even though it did not disclose the claimed invention. In other words, "after the AIA, if the existence of the sale is public, the details of the invention need not be publicly disclosed in the terms of sale." Slip op at 27.

Finally, the Federal Circuit disagreed with the district court's finding that the Helsinn invention was not "ready for patenting" more than one year prior to the application filing dates. The Federal Circuit noted that the district court erred in using FDA market approval as the appropriate standard. Instead, an invention is ready for patenting when it has been reduced to practice, which happens when "the inventor (1) constructed an embodiment . . . that met all the limitations and (2) determined that the invention would work for its intended purpose." In re Omeprazole Patent Litig., 536 F.3d 1361, 1373 (Fed. Cir. 2008). Since Teva proved that the Helsinn technology met that standard well prior to the application filing date, it was "ready for patenting" for purposes of the on sale bar.

Practical Significance

The Helsinn decision is significant for several reasons. First, it is the only Federal Circuit decision to date interpreting the controversial prior art provisions of the AIA. Given the issue's wide significance, the AIA's effect on defining prior art likely will be the subject of future panel and en banc decisions at the Federal Circuit, and ultimately review by the Supreme Court.

Second, Helsinn establishes that an offer for sale is prior art under the AIA if the sale itself is public, even if the details of the underlying invention are secret. That result is at odds with the USPTO's interpretation of AIA § 102(a)(1). The court did not address whether an offer for sale is prior art if both the offer and the invention details are secret, and that issue will remain uncertain until the courts confront it in a future case.

Finally, the court's analysis in Helsinn suggests a tendency to preserve the pre-AIA prior art case law, rooted in public policy concerns about preventing patents on inventions already available to the public, in the absence of unambiguous Congressional statements rejecting those rules. Although Helsinn did not concern a secret public use, such as the corset in Egbert, the same considerations may cause the court to preserve the long-standing rule that a secret public use is prior art. In addition, it remains unclear whether the AIA abrogated the Metallizing Engineering doctrine, which holds that an inventor's own commercial sale of a product made by a secret process is prior art available to defeated a patent on the process. See Metallizing Eng'g Co. v. Kenyon Bearing & Auto Parts Co., 153 F.2d 516 (2d Cir. 1946). Although the USPTO has interpreted the AIA as rejecting that doctrine, the court's analysis in Helsinn could apply to preserve the doctrine.

Originally published May 04, 2017

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

David A. Randall
In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.